nodes	percent_of_prediction	percent_of_DWPC	metapath
Dantrolene—RYR3—smooth muscle tissue—systemic scleroderma	0.0224	0.219	CbGeAlD
Dantrolene—RYR3—digestive system—systemic scleroderma	0.0177	0.173	CbGeAlD
Dantrolene—RYR3—tendon—systemic scleroderma	0.0169	0.165	CbGeAlD
Dantrolene—RYR1—smooth muscle tissue—systemic scleroderma	0.0161	0.157	CbGeAlD
Dantrolene—RYR3—lung—systemic scleroderma	0.0148	0.145	CbGeAlD
Dantrolene—RYR1—tendon—systemic scleroderma	0.0121	0.118	CbGeAlD
Dantrolene—CYP3A4—digestive system—systemic scleroderma	0.00221	0.0216	CbGeAlD
Dantrolene—Tachycardia—Leflunomide—systemic scleroderma	0.00142	0.00158	CcSEcCtD
Dantrolene—Dry mouth—Mycophenolic acid—systemic scleroderma	0.00141	0.00157	CcSEcCtD
Dantrolene—Anaemia—Lisinopril—systemic scleroderma	0.00141	0.00157	CcSEcCtD
Dantrolene—Hyperhidrosis—Leflunomide—systemic scleroderma	0.0014	0.00156	CcSEcCtD
Dantrolene—Hepatic failure—Methotrexate—systemic scleroderma	0.0014	0.00156	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.0014	0.00156	CcSEcCtD
Dantrolene—Confusional state—Mycophenolic acid—systemic scleroderma	0.0014	0.00155	CcSEcCtD
Dantrolene—Abdominal pain—Captopril—systemic scleroderma	0.00139	0.00155	CcSEcCtD
Dantrolene—Body temperature increased—Captopril—systemic scleroderma	0.00139	0.00155	CcSEcCtD
Dantrolene—Anorexia—Leflunomide—systemic scleroderma	0.00138	0.00154	CcSEcCtD
Dantrolene—Nausea—Pentoxifylline—systemic scleroderma	0.00138	0.00154	CcSEcCtD
Dantrolene—Chills—Mycophenolate mofetil—systemic scleroderma	0.00138	0.00154	CcSEcCtD
Dantrolene—Malaise—Lisinopril—systemic scleroderma	0.00138	0.00153	CcSEcCtD
Dantrolene—Diarrhoea—Mometasone—systemic scleroderma	0.00137	0.00153	CcSEcCtD
Dantrolene—Leukopenia—Lisinopril—systemic scleroderma	0.00137	0.00152	CcSEcCtD
Dantrolene—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.00136	0.00151	CcSEcCtD
Dantrolene—Tachycardia—Mycophenolic acid—systemic scleroderma	0.00135	0.00151	CcSEcCtD
Dantrolene—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.00134	0.00149	CcSEcCtD
Dantrolene—Muscular weakness—Prednisone—systemic scleroderma	0.00133	0.00148	CcSEcCtD
Dantrolene—Visual disturbance—Methotrexate—systemic scleroderma	0.00133	0.00148	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.00132	0.00147	CcSEcCtD
Dantrolene—Anorexia—Mycophenolic acid—systemic scleroderma	0.00132	0.00147	CcSEcCtD
Dantrolene—Tension—Mycophenolate mofetil—systemic scleroderma	0.00131	0.00146	CcSEcCtD
Dantrolene—Insomnia—Leflunomide—systemic scleroderma	0.00131	0.00146	CcSEcCtD
Dantrolene—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.00131	0.00146	CcSEcCtD
Dantrolene—Myalgia—Lisinopril—systemic scleroderma	0.0013	0.00145	CcSEcCtD
Dantrolene—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.0013	0.00145	CcSEcCtD
Dantrolene—Back pain—Mycophenolate mofetil—systemic scleroderma	0.0013	0.00144	CcSEcCtD
Dantrolene—Discomfort—Lisinopril—systemic scleroderma	0.00129	0.00143	CcSEcCtD
Dantrolene—Dyspepsia—Leflunomide—systemic scleroderma	0.00128	0.00142	CcSEcCtD
Dantrolene—Vomiting—Mometasone—systemic scleroderma	0.00127	0.00142	CcSEcCtD
Dantrolene—Dry mouth—Lisinopril—systemic scleroderma	0.00127	0.00142	CcSEcCtD
Dantrolene—Feeling abnormal—Azathioprine—systemic scleroderma	0.00127	0.00141	CcSEcCtD
Dantrolene—Rash—Mometasone—systemic scleroderma	0.00126	0.00141	CcSEcCtD
Dantrolene—Asthenia—Captopril—systemic scleroderma	0.00126	0.00141	CcSEcCtD
Dantrolene—Dermatitis—Mometasone—systemic scleroderma	0.00126	0.00141	CcSEcCtD
Dantrolene—Decreased appetite—Leflunomide—systemic scleroderma	0.00126	0.00141	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.00126	0.00141	CcSEcCtD
Dantrolene—Confusional state—Lisinopril—systemic scleroderma	0.00126	0.0014	CcSEcCtD
Dantrolene—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00126	0.0014	CcSEcCtD
Dantrolene—Headache—Mometasone—systemic scleroderma	0.00126	0.0014	CcSEcCtD
Dantrolene—Insomnia—Mycophenolic acid—systemic scleroderma	0.00125	0.00139	CcSEcCtD
Dantrolene—Fatigue—Leflunomide—systemic scleroderma	0.00125	0.00139	CcSEcCtD
Dantrolene—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00125	0.00139	CcSEcCtD
Dantrolene—Pruritus—Captopril—systemic scleroderma	0.00125	0.00139	CcSEcCtD
Dantrolene—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.00124	0.00138	CcSEcCtD
Dantrolene—Pain—Leflunomide—systemic scleroderma	0.00124	0.00138	CcSEcCtD
Dantrolene—Constipation—Leflunomide—systemic scleroderma	0.00124	0.00138	CcSEcCtD
Dantrolene—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.00124	0.00138	CcSEcCtD
Dantrolene—Somnolence—Mycophenolic acid—systemic scleroderma	0.00123	0.00137	CcSEcCtD
Dantrolene—Thrombocytopenia—Lisinopril—systemic scleroderma	0.00122	0.00136	CcSEcCtD
Dantrolene—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00122	0.00136	CcSEcCtD
Dantrolene—Tachycardia—Lisinopril—systemic scleroderma	0.00122	0.00136	CcSEcCtD
Dantrolene—Body temperature increased—Azathioprine—systemic scleroderma	0.00121	0.00135	CcSEcCtD
Dantrolene—Abdominal pain—Azathioprine—systemic scleroderma	0.00121	0.00135	CcSEcCtD
Dantrolene—Malaise—Mycophenolate mofetil—systemic scleroderma	0.00121	0.00134	CcSEcCtD
Dantrolene—Hyperhidrosis—Lisinopril—systemic scleroderma	0.00121	0.00134	CcSEcCtD
Dantrolene—Diarrhoea—Captopril—systemic scleroderma	0.0012	0.00134	CcSEcCtD
Dantrolene—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.0012	0.00134	CcSEcCtD
Dantrolene—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.0012	0.00133	CcSEcCtD
Dantrolene—Feeling abnormal—Leflunomide—systemic scleroderma	0.0012	0.00133	CcSEcCtD
Dantrolene—Fatigue—Mycophenolic acid—systemic scleroderma	0.00119	0.00133	CcSEcCtD
Dantrolene—Nausea—Mometasone—systemic scleroderma	0.00119	0.00133	CcSEcCtD
Dantrolene—Anorexia—Lisinopril—systemic scleroderma	0.00119	0.00132	CcSEcCtD
Dantrolene—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00119	0.00132	CcSEcCtD
Dantrolene—Constipation—Mycophenolic acid—systemic scleroderma	0.00118	0.00132	CcSEcCtD
Dantrolene—Pain—Mycophenolic acid—systemic scleroderma	0.00118	0.00132	CcSEcCtD
Dantrolene—Dizziness—Captopril—systemic scleroderma	0.00116	0.0013	CcSEcCtD
Dantrolene—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.00116	0.00129	CcSEcCtD
Dantrolene—Depression—Prednisone—systemic scleroderma	0.00116	0.00129	CcSEcCtD
Dantrolene—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.00116	0.00129	CcSEcCtD
Dantrolene—Urticaria—Leflunomide—systemic scleroderma	0.00115	0.00128	CcSEcCtD
Dantrolene—Body temperature increased—Leflunomide—systemic scleroderma	0.00115	0.00128	CcSEcCtD
Dantrolene—Abdominal pain—Leflunomide—systemic scleroderma	0.00115	0.00128	CcSEcCtD
Dantrolene—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00114	0.00127	CcSEcCtD
Dantrolene—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.00114	0.00127	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.00114	0.00127	CcSEcCtD
Dantrolene—Hypersensitivity—Azathioprine—systemic scleroderma	0.00113	0.00126	CcSEcCtD
Dantrolene—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00113	0.00126	CcSEcCtD
Dantrolene—Insomnia—Lisinopril—systemic scleroderma	0.00113	0.00126	CcSEcCtD
Dantrolene—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.00113	0.00125	CcSEcCtD
Dantrolene—Vomiting—Captopril—systemic scleroderma	0.00112	0.00125	CcSEcCtD
Dantrolene—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.00111	0.00124	CcSEcCtD
Dantrolene—Rash—Captopril—systemic scleroderma	0.00111	0.00124	CcSEcCtD
Dantrolene—Dermatitis—Captopril—systemic scleroderma	0.00111	0.00124	CcSEcCtD
Dantrolene—Somnolence—Lisinopril—systemic scleroderma	0.00111	0.00123	CcSEcCtD
Dantrolene—Headache—Captopril—systemic scleroderma	0.0011	0.00123	CcSEcCtD
Dantrolene—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.0011	0.00123	CcSEcCtD
Dantrolene—Dyspepsia—Lisinopril—systemic scleroderma	0.0011	0.00122	CcSEcCtD
Dantrolene—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00109	0.00122	CcSEcCtD
Dantrolene—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00109	0.00122	CcSEcCtD
Dantrolene—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00109	0.00122	CcSEcCtD
Dantrolene—Decreased appetite—Lisinopril—systemic scleroderma	0.00108	0.00121	CcSEcCtD
Dantrolene—Eosinophilia—Methotrexate—systemic scleroderma	0.00108	0.0012	CcSEcCtD
Dantrolene—Fatigue—Lisinopril—systemic scleroderma	0.00108	0.0012	CcSEcCtD
Dantrolene—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00107	0.00119	CcSEcCtD
Dantrolene—Hypersensitivity—Leflunomide—systemic scleroderma	0.00107	0.00119	CcSEcCtD
Dantrolene—Pain—Lisinopril—systemic scleroderma	0.00107	0.00119	CcSEcCtD
Dantrolene—Constipation—Lisinopril—systemic scleroderma	0.00107	0.00119	CcSEcCtD
Dantrolene—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.00107	0.00119	CcSEcCtD
Dantrolene—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.00106	0.00118	CcSEcCtD
Dantrolene—Diarrhoea—Azathioprine—systemic scleroderma	0.00105	0.00117	CcSEcCtD
Dantrolene—Haemoglobin—Prednisone—systemic scleroderma	0.00105	0.00117	CcSEcCtD
Dantrolene—Nausea—Captopril—systemic scleroderma	0.00105	0.00117	CcSEcCtD
Dantrolene—Haemorrhage—Prednisone—systemic scleroderma	0.00104	0.00116	CcSEcCtD
Dantrolene—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.00104	0.00116	CcSEcCtD
Dantrolene—Asthenia—Leflunomide—systemic scleroderma	0.00104	0.00116	CcSEcCtD
Dantrolene—Feeling abnormal—Lisinopril—systemic scleroderma	0.00103	0.00114	CcSEcCtD
Dantrolene—Pruritus—Leflunomide—systemic scleroderma	0.00103	0.00114	CcSEcCtD
Dantrolene—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00102	0.00114	CcSEcCtD
Dantrolene—Dizziness—Azathioprine—systemic scleroderma	0.00102	0.00113	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000995	0.00111	CcSEcCtD
Dantrolene—Asthenia—Mycophenolic acid—systemic scleroderma	0.000993	0.00111	CcSEcCtD
Dantrolene—Diarrhoea—Leflunomide—systemic scleroderma	0.000993	0.00111	CcSEcCtD
Dantrolene—Urticaria—Lisinopril—systemic scleroderma	0.000991	0.0011	CcSEcCtD
Dantrolene—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000988	0.0011	CcSEcCtD
Dantrolene—Abdominal pain—Lisinopril—systemic scleroderma	0.000986	0.0011	CcSEcCtD
Dantrolene—Body temperature increased—Lisinopril—systemic scleroderma	0.000986	0.0011	CcSEcCtD
Dantrolene—Pruritus—Mycophenolic acid—systemic scleroderma	0.00098	0.00109	CcSEcCtD
Dantrolene—Vomiting—Azathioprine—systemic scleroderma	0.000977	0.00109	CcSEcCtD
Dantrolene—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000971	0.00108	CcSEcCtD
Dantrolene—Drowsiness—Methotrexate—systemic scleroderma	0.000971	0.00108	CcSEcCtD
Dantrolene—Rash—Azathioprine—systemic scleroderma	0.000969	0.00108	CcSEcCtD
Dantrolene—Dermatitis—Azathioprine—systemic scleroderma	0.000968	0.00108	CcSEcCtD
Dantrolene—Depression—Methotrexate—systemic scleroderma	0.000968	0.00108	CcSEcCtD
Dantrolene—Flushing—Prednisone—systemic scleroderma	0.000968	0.00108	CcSEcCtD
Dantrolene—Headache—Azathioprine—systemic scleroderma	0.000963	0.00107	CcSEcCtD
Dantrolene—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000962	0.00107	CcSEcCtD
Dantrolene—Dizziness—Leflunomide—systemic scleroderma	0.00096	0.00107	CcSEcCtD
Dantrolene—Renal failure—Methotrexate—systemic scleroderma	0.000954	0.00106	CcSEcCtD
Dantrolene—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.00095	0.00106	CcSEcCtD
Dantrolene—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000947	0.00106	CcSEcCtD
Dantrolene—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000934	0.00104	CcSEcCtD
Dantrolene—Pain—Mycophenolate mofetil—systemic scleroderma	0.000934	0.00104	CcSEcCtD
Dantrolene—Sweating—Methotrexate—systemic scleroderma	0.00093	0.00104	CcSEcCtD
Dantrolene—Haematuria—Methotrexate—systemic scleroderma	0.000925	0.00103	CcSEcCtD
Dantrolene—Vomiting—Leflunomide—systemic scleroderma	0.000923	0.00103	CcSEcCtD
Dantrolene—Hypersensitivity—Lisinopril—systemic scleroderma	0.000919	0.00102	CcSEcCtD
Dantrolene—Dizziness—Mycophenolic acid—systemic scleroderma	0.000916	0.00102	CcSEcCtD
Dantrolene—Rash—Leflunomide—systemic scleroderma	0.000915	0.00102	CcSEcCtD
Dantrolene—Dermatitis—Leflunomide—systemic scleroderma	0.000914	0.00102	CcSEcCtD
Dantrolene—Nausea—Azathioprine—systemic scleroderma	0.000913	0.00102	CcSEcCtD
Dantrolene—Headache—Leflunomide—systemic scleroderma	0.000909	0.00101	CcSEcCtD
Dantrolene—Erythema—Prednisone—systemic scleroderma	0.000908	0.00101	CcSEcCtD
Dantrolene—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.0009	0.001	CcSEcCtD
Dantrolene—Asthenia—Lisinopril—systemic scleroderma	0.000895	0.000997	CcSEcCtD
Dantrolene—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000893	0.000995	CcSEcCtD
Dantrolene—Pruritus—Lisinopril—systemic scleroderma	0.000882	0.000983	CcSEcCtD
Dantrolene—Vomiting—Mycophenolic acid—systemic scleroderma	0.00088	0.000981	CcSEcCtD
Dantrolene—Haemoglobin—Methotrexate—systemic scleroderma	0.000876	0.000975	CcSEcCtD
Dantrolene—Rash—Mycophenolic acid—systemic scleroderma	0.000873	0.000972	CcSEcCtD
Dantrolene—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000872	0.000971	CcSEcCtD
Dantrolene—Haemorrhage—Methotrexate—systemic scleroderma	0.000871	0.00097	CcSEcCtD
Dantrolene—Hepatitis—Methotrexate—systemic scleroderma	0.000871	0.00097	CcSEcCtD
Dantrolene—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000868	0.000967	CcSEcCtD
Dantrolene—Headache—Mycophenolic acid—systemic scleroderma	0.000867	0.000966	CcSEcCtD
Dantrolene—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000864	0.000962	CcSEcCtD
Dantrolene—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000864	0.000962	CcSEcCtD
Dantrolene—Nausea—Leflunomide—systemic scleroderma	0.000862	0.00096	CcSEcCtD
Dantrolene—Vision blurred—Prednisone—systemic scleroderma	0.000855	0.000953	CcSEcCtD
Dantrolene—Diarrhoea—Lisinopril—systemic scleroderma	0.000853	0.00095	CcSEcCtD
Dantrolene—Ill-defined disorder—Prednisone—systemic scleroderma	0.000842	0.000938	CcSEcCtD
Dantrolene—Visual impairment—Methotrexate—systemic scleroderma	0.00084	0.000935	CcSEcCtD
Dantrolene—Anaemia—Prednisone—systemic scleroderma	0.000839	0.000934	CcSEcCtD
Dantrolene—Dizziness—Lisinopril—systemic scleroderma	0.000825	0.000919	CcSEcCtD
Dantrolene—Nausea—Mycophenolic acid—systemic scleroderma	0.000822	0.000916	CcSEcCtD
Dantrolene—Malaise—Prednisone—systemic scleroderma	0.000818	0.000912	CcSEcCtD
Dantrolene—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000805	0.000897	CcSEcCtD
Dantrolene—Vomiting—Lisinopril—systemic scleroderma	0.000793	0.000883	CcSEcCtD
Dantrolene—Rash—Lisinopril—systemic scleroderma	0.000786	0.000876	CcSEcCtD
Dantrolene—Convulsion—Prednisone—systemic scleroderma	0.000786	0.000876	CcSEcCtD
Dantrolene—Dermatitis—Lisinopril—systemic scleroderma	0.000786	0.000875	CcSEcCtD
Dantrolene—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000784	0.000873	CcSEcCtD
Dantrolene—Hypertension—Prednisone—systemic scleroderma	0.000784	0.000873	CcSEcCtD
Dantrolene—Chills—Methotrexate—systemic scleroderma	0.000782	0.000871	CcSEcCtD
Dantrolene—Headache—Lisinopril—systemic scleroderma	0.000781	0.00087	CcSEcCtD
Dantrolene—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000773	0.000861	CcSEcCtD
Dantrolene—Myalgia—Prednisone—systemic scleroderma	0.000773	0.000861	CcSEcCtD
Dantrolene—Discomfort—Prednisone—systemic scleroderma	0.000763	0.00085	CcSEcCtD
Dantrolene—Erythema—Methotrexate—systemic scleroderma	0.000758	0.000845	CcSEcCtD
Dantrolene—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000748	0.000833	CcSEcCtD
Dantrolene—Dysgeusia—Methotrexate—systemic scleroderma	0.000743	0.000827	CcSEcCtD
Dantrolene—Nausea—Lisinopril—systemic scleroderma	0.000741	0.000825	CcSEcCtD
Dantrolene—Anaphylactic shock—Prednisone—systemic scleroderma	0.000741	0.000825	CcSEcCtD
Dantrolene—Back pain—Methotrexate—systemic scleroderma	0.000734	0.000817	CcSEcCtD
Dantrolene—Tachycardia—Prednisone—systemic scleroderma	0.000723	0.000805	CcSEcCtD
Dantrolene—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000723	0.000805	CcSEcCtD
Dantrolene—Hyperhidrosis—Prednisone—systemic scleroderma	0.000716	0.000798	CcSEcCtD
Dantrolene—Vision blurred—Methotrexate—systemic scleroderma	0.000715	0.000796	CcSEcCtD
Dantrolene—Anorexia—Prednisone—systemic scleroderma	0.000706	0.000786	CcSEcCtD
Dantrolene—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000704	0.000784	CcSEcCtD
Dantrolene—Anaemia—Methotrexate—systemic scleroderma	0.000701	0.000781	CcSEcCtD
Dantrolene—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000695	0.000774	CcSEcCtD
Dantrolene—Rash—Mycophenolate mofetil—systemic scleroderma	0.000689	0.000767	CcSEcCtD
Dantrolene—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000688	0.000767	CcSEcCtD
Dantrolene—Headache—Mycophenolate mofetil—systemic scleroderma	0.000685	0.000762	CcSEcCtD
Dantrolene—Malaise—Methotrexate—systemic scleroderma	0.000684	0.000762	CcSEcCtD
Dantrolene—Leukopenia—Methotrexate—systemic scleroderma	0.000679	0.000756	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000675	0.000752	CcSEcCtD
Dantrolene—Insomnia—Prednisone—systemic scleroderma	0.00067	0.000746	CcSEcCtD
Dantrolene—Convulsion—Methotrexate—systemic scleroderma	0.000657	0.000732	CcSEcCtD
Dantrolene—Dyspepsia—Prednisone—systemic scleroderma	0.000652	0.000726	CcSEcCtD
Dantrolene—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000649	0.000723	CcSEcCtD
Dantrolene—Myalgia—Methotrexate—systemic scleroderma	0.000646	0.000719	CcSEcCtD
Dantrolene—Decreased appetite—Prednisone—systemic scleroderma	0.000644	0.000717	CcSEcCtD
Dantrolene—Fatigue—Prednisone—systemic scleroderma	0.000639	0.000711	CcSEcCtD
Dantrolene—Discomfort—Methotrexate—systemic scleroderma	0.000638	0.000711	CcSEcCtD
Dantrolene—Constipation—Prednisone—systemic scleroderma	0.000633	0.000705	CcSEcCtD
Dantrolene—Confusional state—Methotrexate—systemic scleroderma	0.000624	0.000695	CcSEcCtD
Dantrolene—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000619	0.000689	CcSEcCtD
Dantrolene—Feeling abnormal—Prednisone—systemic scleroderma	0.00061	0.00068	CcSEcCtD
Dantrolene—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000606	0.000675	CcSEcCtD
Dantrolene—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000606	0.000675	CcSEcCtD
Dantrolene—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000598	0.000667	CcSEcCtD
Dantrolene—Anorexia—Methotrexate—systemic scleroderma	0.00059	0.000657	CcSEcCtD
Dantrolene—Urticaria—Prednisone—systemic scleroderma	0.000588	0.000655	CcSEcCtD
Dantrolene—Abdominal pain—Prednisone—systemic scleroderma	0.000585	0.000652	CcSEcCtD
Dantrolene—Body temperature increased—Prednisone—systemic scleroderma	0.000585	0.000652	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000564	0.000628	CcSEcCtD
Dantrolene—Insomnia—Methotrexate—systemic scleroderma	0.00056	0.000624	CcSEcCtD
Dantrolene—Somnolence—Methotrexate—systemic scleroderma	0.00055	0.000613	CcSEcCtD
Dantrolene—Hypersensitivity—Prednisone—systemic scleroderma	0.000546	0.000608	CcSEcCtD
Dantrolene—Dyspepsia—Methotrexate—systemic scleroderma	0.000545	0.000607	CcSEcCtD
Dantrolene—Decreased appetite—Methotrexate—systemic scleroderma	0.000538	0.000599	CcSEcCtD
Dantrolene—Fatigue—Methotrexate—systemic scleroderma	0.000534	0.000594	CcSEcCtD
Dantrolene—Asthenia—Prednisone—systemic scleroderma	0.000531	0.000592	CcSEcCtD
Dantrolene—Pain—Methotrexate—systemic scleroderma	0.000529	0.00059	CcSEcCtD
Dantrolene—Pruritus—Prednisone—systemic scleroderma	0.000524	0.000584	CcSEcCtD
Dantrolene—Feeling abnormal—Methotrexate—systemic scleroderma	0.00051	0.000568	CcSEcCtD
Dantrolene—Diarrhoea—Prednisone—systemic scleroderma	0.000507	0.000564	CcSEcCtD
Dantrolene—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000506	0.000564	CcSEcCtD
Dantrolene—Urticaria—Methotrexate—systemic scleroderma	0.000492	0.000548	CcSEcCtD
Dantrolene—Dizziness—Prednisone—systemic scleroderma	0.00049	0.000546	CcSEcCtD
Dantrolene—Abdominal pain—Methotrexate—systemic scleroderma	0.000489	0.000545	CcSEcCtD
Dantrolene—Body temperature increased—Methotrexate—systemic scleroderma	0.000489	0.000545	CcSEcCtD
Dantrolene—Vomiting—Prednisone—systemic scleroderma	0.000471	0.000525	CcSEcCtD
Dantrolene—Rash—Prednisone—systemic scleroderma	0.000467	0.00052	CcSEcCtD
Dantrolene—Dermatitis—Prednisone—systemic scleroderma	0.000467	0.00052	CcSEcCtD
Dantrolene—Headache—Prednisone—systemic scleroderma	0.000464	0.000517	CcSEcCtD
Dantrolene—Hypersensitivity—Methotrexate—systemic scleroderma	0.000456	0.000508	CcSEcCtD
Dantrolene—Asthenia—Methotrexate—systemic scleroderma	0.000444	0.000495	CcSEcCtD
Dantrolene—Nausea—Prednisone—systemic scleroderma	0.00044	0.00049	CcSEcCtD
Dantrolene—Pruritus—Methotrexate—systemic scleroderma	0.000438	0.000488	CcSEcCtD
Dantrolene—Diarrhoea—Methotrexate—systemic scleroderma	0.000424	0.000472	CcSEcCtD
Dantrolene—Dizziness—Methotrexate—systemic scleroderma	0.000409	0.000456	CcSEcCtD
Dantrolene—Vomiting—Methotrexate—systemic scleroderma	0.000394	0.000438	CcSEcCtD
Dantrolene—Rash—Methotrexate—systemic scleroderma	0.00039	0.000435	CcSEcCtD
Dantrolene—Dermatitis—Methotrexate—systemic scleroderma	0.00039	0.000434	CcSEcCtD
Dantrolene—Headache—Methotrexate—systemic scleroderma	0.000388	0.000432	CcSEcCtD
Dantrolene—Nausea—Methotrexate—systemic scleroderma	0.000368	0.00041	CcSEcCtD
